Molecular subtype specific therapy in high grade serous ovarian cancer [ 2015 - 2017 ]

Research Grant

Researchers: Prof David Bowtell (Principal investigator) ,  A/Pr Clare Scott

Brief description High grade serous ovarian cancer (HGSC) is the most common type of ovarian cancer, accounting for about two thirds of all deaths from the disease.Several years ago we identified distinct subtypes of HGSC (C1, C2, C4, C5) based on patterns of gene activity. We found that women with the C5 subtype generally had poor survival, and we mapped genes that were specifically active in C5 tumours. In this application we aim to develop therapies that are specifically targeted to the C5 HGSC.

Funding Amount $AUD 832,254.16

Funding Scheme Project Grants

Notes Standard Project Grant